Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium chloride injection IP 0.9% W/V, commonly known as normal saline, is a sterile, isotonic solution of sodium chloride in water for injection, formulated in accordance with Indian Pharmacopoeia (IP) standards. It contains 0.9% w/v sodium chloride, which matches the osmolarity of human blood plasma. It is widely used in clinical settings for intravenous fluid and electrolyte replenishment, the treatment of dehydration and hypovolemia, and as a sterile vehicle or diluent for the administration of compatible intravenous medications. Originally developed and manufactured by Puniska Healthcare, the product became part of Amneal Pharmaceuticals' portfolio following its acquisition of Puniska in November 2021.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride (Amneal Pharmaceuticals, Inc.).